妊娠期糖尿病与晚期早产:产前糖皮质激素暴露与否的结局
基于美国2016至2020年生命统计数据的队列研究,纳入110197例在34.0至36.6周分娩的妊娠期糖尿病单胎无畸形产妇,其中23028例(20.9%)接受产前糖皮质激素。暴露组新生儿复合不良结局(校正相对风险1.24,95%置信区间1.20-1.28)与母亲复合不良结局(校正相对风险1.34,95%置信区间1.18-1.52)均显著高于未暴露组。
要点
- 妊娠期糖尿病晚期早产者接受产前糖皮质激素与新生儿复合不良结局风险升高相关(校正相对风险1.24)。
- 暴露组母亲复合不良结局风险亦升高(校正相对风险1.34),含重症监护入住、输血、非计划子宫切除。
- 5年间产前激素暴露率保持稳定(年度平均百分比变化10.7,95%置信区间-5.4至29.4)。
核心结论
- 妊娠期糖尿病产妇在晚期早产分娩时接受产前糖皮质激素,其新生儿和母亲不良结局风险均高于未暴露者。
研究设计与样本
- 基于美国2016至2020年生命统计数据的队列研究,纳入单胎、无畸形、在34.0至36.6周分娩且有已知产前糖皮质激素暴露状态的妊娠期糖尿病产妇。
- 采用多变量泊松回归模型估计校正相对风险和95%置信区间。
主要发现
- 新生儿复合不良结局在暴露组为每1000例活产137.1例,未暴露组为每1000例活产216.5例,校正相对风险1.24(95%置信区间1.20-1.28)。
- 新生儿复合结局中的立即辅助通气、插管超过6小时和表面活性物质使用在暴露组显著高于未暴露组。
- 母亲复合不良结局在暴露组显著高于未暴露组,校正相对风险1.34(95%置信区间1.18-1.52)。
- 母亲复合结局中的重症监护入住、输血和非计划子宫切除在暴露组显著更高。
- 产前激素暴露率5年间保持稳定,年度平均百分比变化10.7(95%置信区间-5.4至29.4)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unlike pregestational diabetes mellitus, the American College of Obstetricians and Gynecologists recommends antenatal corticosteroids in those with gestational diabetes mellitus at risk for preterm birth. However, this recommendation is based on limited data, only 10.6% of the Antenatal Late Preterm Steroids study sample had gestational diabetes mellitus. There is a paucity of data on the risk of neonatal respiratory and other morbidity in this population. OBJECTIVE: This study aimed to examine respiratory outcomes in parturients with gestational diabetes mellitus who received antenatal corticosteroids and delivered during the late preterm period vs those who did not. STUDY DESIGN: This population-based cohort study used the US Vital Statistics dataset between 2016 to 2020. The inclusion criteria were singleton, nonanomalous individuals who delivered between 34.0 to 36.6 weeks with gestational diabetes mellitus and known status of antepartum corticosteroid exposure. The primary outcome, a composite neonatal adverse outcome, included Apgar score <5 at 5 minutes, immediate assisted ventilation, assisted ventilation >6 hours, surfactant use, seizure, or neonatal mortality. The secondary outcome was a composite maternal adverse outcome, including maternal blood transfusion, ruptured uterus, unplanned hysterectomy, and admission to the intensive care unit. Multivariable Poisson regression models were used to estimate adjusted relative risks and 95% confidence intervals. Average annual percent change was calculated to assess changes in rates of corticosteroid exposure over the study period. RESULTS: Of 19 million births during the study period, 110,197 (0.6%) met the inclusion criteria, and among them, 23,028 (20.9%) individuals with gestational diabetes mellitus received antenatal corticosteroids. The rate of antenatal steroid exposure remained stable over the 5 years (APC=10.7; 95% confidence interval, -5.4 to 29.4). The composite neonatal adverse outcome was significantly higher among those who received corticosteroids than among those who did not (137.1 vs 216.5 per 1000 live births; adjusted relative risk 1.24; 95% confidence interval, 1.20-1.28). Three components of the composite neonatal adverse outcome-immediate assisted ventilation, intubation >6 hours, and surfactant use-were significantly higher with exposure than without. In addition, the composite maternal adverse outcome was significantly higher among those who received corticosteroids (adjusted relative risk, 1.34; 95% confidence interval, 1.18-1.52). Three components of the composite maternal adverse outcome-admission to intensive care unit, blood transfusion, and unplanned hysterectomy-were significantly higher among the exposed group. Subgroup analysis, among large for gestational age, by gestational age, and race and ethnicity, confirm the trend of increased likelihood of adverse outcomes with exposure to corticosteroid. CONCLUSION: Individuals with gestational diabetes mellitus and antenatal corticosteroid exposure, who delivered in the late preterm, were at higher risk of neonatal and maternal adverse outcomes than those unexposed to corticosteroid.
引用
- Nazeer SA, Chen HY, Chauhan SP, et al. Gestational diabetes mellitus and late preterm birth: outcomes with and without antenatal corticosteroid exposure. Am J Obstet Gynecol MFM. 2024. PMID: 38242498. doi:10.1016/j.ajogmf.2023.101268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。